Avitabile, Elisa; Menotti, Laura; Giordani, Barbara; Croatti, Vanessa; Parolin, Carola; Vitali, Beatrice, Vaginal Lactobacilli Supernatants Protect from Herpes Simplex Virus Type 1 Infection in Cell Culture Models, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2024, 25, pp. 2492 - 2502 [articolo]Open Access
Appolloni I.; Alessandrini F.; Menotti L.; Avitabile E.; Marubbi D.; Piga N.; Ceresa D.; Piaggio F.; Campadelli-Fiume G.; Malatesta P., Specificity, safety, efficacy of egfrviii-retargeted oncolytic hsv for xenotransplanted human glioblastoma, «VIRUSES», 2021, 13, pp. 1677 - 1689 [articolo]Open Access
Menotti L.; Avitabile E., Herpes simplex virus oncolytic immunovirotherapy: The blossoming branch of multimodal therapy, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2020, 21, Article number: 8310, pp. 1 - 26 [articolo]Open Access
Reno C.; Lenzi J.; Golinelli D.; Gori D.; Signorelli C.; Kraemer J.; Stoto M.A.; Avitabile E.; Landini M.P.; Lazzarotto T.; Re M.C.; Rucci P.; Taliani G.; Trere' D.; Vocale C.; Fantini M.P., SARS-CoV-2/COVID-19 testing: The tower of babel, «ACTA BIO-MEDICA DE L'ATENEO PARMENSE», 2020, 91, pp. 1 - 10 [articolo]Open Access
Alessandrini, Francesco; Menotti, Laura; Avitabile, Elisa; Appolloni, Irene; Ceresa, Davide; Marubbi, Daniela; Campadelli-Fiume, Gabriella; Malatesta, Paolo, Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model, «ONCOGENE», 2019, 38, pp. 4467 - 4479 [articolo]Open Access
Menotti, Laura; Avitabile, Elisa; Gatta, Valentina; Malatesta, Paolo; Petrovic, Biljana; Campadelli-Fiume, Gabriella, HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses, «VIRUSES», 2018, 10, Article number: 352, pp. 1 - 29 [articolo]Open Access
Campadelli, MARIA GABRIELLA; Petrovic, Biljana; Leoni, Valerio; Gianni, Tatiana; Avitabile, Elisa; Casiraghi, Costanza; Gatta, Valentina, Retargeting strategies for oncolytic herpes simplex viruses, «VIRUSES», 2016, 8, Article number: 63, pp. 63 - 73 [articolo]Open Access
Campadelli-Fiume G.; Menotti L.; Avitabile E.; Gianni T., Viral and cellular contributions to herpes simplex virus entry into the cell, «CURRENT OPINION IN VIROLOGY», 2012, 2, pp. 28 - 36 [articolo]
Avitabile E; Forghieri C; Campadelli-Fiume G., Cross talk among the glycoproteins involved in herpes simplex virus entry and fusion: the interaction between gB and gH/gL does not necessarily require gD., «JOURNAL OF VIROLOGY», 2009, 83, pp. 10752 - 10760 [articolo]
Avitabile E.; Forghieri C.; Campadelli-Fiume G., Complexes between Herpes Simplex Virus Glycoproteins gD, gB, and gH Detected in Cells by Complementation of Split Enhanced Green Fluorescent Protein., «JOURNAL OF VIROLOGY», 2007, 81, pp. 11532 - 11537 [articolo]
Campadelli-Fiume G.; Amasio M.; Avitabile E.; Cerretani A.; Forghieri C.; Gianni T; Menotti L., The multipartite system that mediates entry of herpes simplex virus into the cell, «REVIEWS IN MEDICAL VIROLOGY», 2007, 17, pp. 313 - 326 [articolo]
AVITABILE E.; LOMBARDI G.; GIANNI T.; CAPRI M.; CAMPADELLI-FIUME G., Coexpression of UL20p and gK inhibits cell-cell fusion mediated by herpes simplex virus glycoproteins gD, gH-gL, and wild-type gB or an endocytosis-defective gB mutant and downmodulates their cell surface expression., «JOURNAL OF VIROLOGY», 2004, 78, pp. 8015 - 8025 [articolo]
Avitabile E.; Lombardi G.; Campadelli-Fiume G., Herpes simplex virus glycoprotein K, but not its syncytial allele, inhibits cell-cell fusion mediated by the four fusogenic glycoproteins, gD, gB, gH, and gL, «JOURNAL OF VIROLOGY», 2003, 77, pp. 6836 - 6844 [articolo]
Medici M.A.; Sciortino M.T.; Perri D.; Amici C.; Avitabile E.; Ciotti M.; Balestrieri E.; De Smaele E.; Franzoso G.; Mastino A., Protection by herpes simplex virus glycoprotein D against Fas-mediated apoptosis: Role of nuclear factor κB, «THE JOURNAL OF BIOLOGICAL CHEMISTRY», 2003, 278, pp. 36059 - 36067 [articolo]
Orlandi M.; Mantovani B.; Ammar K.; Avitabile E.; Dal Monte P.; Bartolini G., Retinoids and cancer: Antitumoral effects of ATRA, 9-cis RA and the new retinoid IIF on the HL-60 leukemic cell line, «MEDICAL PRINCIPLES AND PRACTICE», 2003, 12, pp. 164 - 169 [articolo]
